Diagnosis and Management of Vasospastic Angina in a Young Woman Wishing to Become Pregnant Authors: Hirohiko Aikawa, Kota Murai, Chizuko Aoki-Kamiya, Jun Yoshimatsu, Teruo Noguchi Published: 2023 ABSTRACT Vasospastic angina can sometimes induce acute myocardial infarction in pregnant women, potentially endangering the lives of mother and child. We describe a case of a young woman with suspected vasospastic angina who wished to become pregnant. Vasospasm provocation testing revealed severe vasospasm, and subsequent appropriate management resulted in successful delivery. History of Presentation A 29-year-old woman presented with chest pain only at rest. The Holter electrocardiogram recorded ST-segment depression at the time of chest pain onset (Figure 1). A trial use of nitroglycerin sublingual tablets was effective. She was suspected to have vasospastic angina (VSA) and wished to become pregnant.Learning Objectives•To understand the significance of proper diagnosis of vasospastic angina in women who wish to become pregnant.•To learn that patients with vasospastic angina may require special management during the perinatal period.Figure 1The Holter Electrocardiogram(A) Electrocardiogram under normal conditions. (B) Electrocardiogram during chest pain. Learning Objectives •To understand the significance of proper diagnosis of vasospastic angina in women who wish to become pregnant.•To learn that patients with vasospastic angina may require special management during the perinatal period. •To understand the significance of proper diagnosis of vasospastic angina in women who wish to become pregnant. To understand the significance of proper diagnosis of vasospastic angina in women who wish to become pregnant. •To learn that patients with vasospastic angina may require special management during the perinatal period. To learn that patients with vasospastic angina may require special management during the perinatal period. The Holter Electrocardiogram (A) Electrocardiogram under normal conditions. (B) Electrocardiogram during chest pain. Past Medical History She had no medical history. Differential Diagnosis The possible differential diagnoses included atherosclerotic coronary artery disease, coronary embolism, and spontaneous coronary artery dissection. Investigations Obstetricians and cardiologists discussed the case and decided to perform invasive coronary catheterization and vasospasm provocation testing to determine a definitive diagnosis and perinatal cardiovascular risk and, if the test was positive, to administer a calcium-channel blocker. Coronary angiography was performed via her right distal radial artery and revealed no stenosis (Figure 2A, Video 1). Vasospasm provocation testing with administration of 50 μg of acetylcholine into the left coronary artery resulted in subocclusion in the left main trunk (LMT) with chest pain, ST-segment depression in the V4 to V6 leads, and hypotension (Figure 2B, Video 2). An intracoronary infusion of isosorbide mononitrate and nicorandil improved the LMT occlusion, eliminated electrocardiogram changes, and increased blood pressure (Figure 2C, Video 3). She was confirmed to have severe VSA.Figure 2Coronary Angiography(A) Baseline. (B) After administration of acetylcholine. (C) After administration of nitrate and nicorandil. Coronary Angiography (A) Baseline. (B) After administration of acetylcholine. (C) After administration of nitrate and nicorandil. Management Diltiazem 200 mg daily was initiated. A few weeks later, she successfully conceived. The effectiveness of diltiazem was recognized when chest pain appeared shortly after the temporary discontinuation of diltiazem because of hyperemesis gravidarum. After the second trimester, her pregnancy progressed without chest pain, and the fetus developed well. Because spontaneous labor did not occur until full term, an induced labor was planned at the 40th week of gestation. At delivery, epidural analgesia was used to prevent vasospasm induction caused by pain stress or hyperventilation. She delivered a healthy girl without any anomaly. Oxytocin was used instead of methylergonovine for postpartum atonic hemorrhage. She had no chest pain or electrocardiogram abnormality in the peripartum period. Discussion VSA is one of the important functional abnormalities of the coronary artery that can contribute to not only variant angina but also coronary microvascular disfunction, acute myocardial infarction, ventricular arrythmias, and sudden cardiac death.1 Previous study has demonstrated that multivessel spasm is associated with poor cardiovascular prognosis, and VSA occurring in the LMT, as in this case, corresponds to multivessel spasm and is considered high risk.2 In pregnant women, it has been suggested that hormonal and nervous system changes that occur during pregnancy seem to trigger VSA.3 Exposure to pain stress, hyperventilation-induced alkalosis, and administration of methylergometrine for flaccid hemostasis can further induce a vasospasm attack. Several studies have reported that VSA plays a role in acute myocardial infarction occurring in pregnant women.4,5 Therefore, proper diagnosis and preventive management of VSA in pregnant women is considered highly significant for the safety of both mother and child. First-line agents for VSA are calcium-channel blockers.6,7 However, there are concerns about teratogenicity reported in animal studies.8 Although the safety of calcium-channel blockers for pregnant women is gradually being established, calcium-channel blockers remain unlicensed for use in pregnancy in many countries.9 It is important to accurately assess the advantages and disadvantages of treatment in light of the certainty and severity of VSA when initiating the medication. Follow-Up After delivery, the patient continues to take diltiazem and has had no recurrence of angina attacks. The child is also growing without any disabilities. The amount of diltiazem ingested by the infant via breast milk is small and is unlikely to adversely affect breastfed infants.10 Conclusions For women who wish to be pregnant, it is important to make a definitive diagnosis of VSA, determine its severity, and provide appropriate treatment. Under conditions of adequate prior consultation with the patient, family, obstetricians, and cardiologists, invasive catheterization including provocation test should be performed, and calcium-channel blocker administration should be considered for VSA. Funding Support and Author Disclosures This work is supported by a grant from the Naohiko Miyata–Asahi Intecc Foundation for Medical Technology and Research. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.